Mediation of endothelium-dependent relaxation: Different response patterns in rat and rabbit basilar artery

Neurological Research

Volumn 19, Issue 5, 1997, Pages 521-526

  Mackert, J L ^a,b   Parsons, A A ^a,c   Wahl, M ^a   Schilling, L ^a,d  

^a UNIVERSITY OF MUNICH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cerebral artery; Cyclooxygenase inhibitor; Endothelium dependent relaxation; In vitro; NO synthase inhibitor

Indexed keywords

ACETYLCHOLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; MALE; NONHUMAN; RABBIT; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0030883270     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1997.11740851     Document Type: Article

References (7)

1. Wahl M, Schilling L. Regulation of cerebral blood flow - a brief review. Acta Neurochir 1993; 59 (Suppl): 3-10
2. 2 and prostacyclin. Pharmacol Rev 1979; 30: 292-331
3. Ignarro LJ, Buga CM, Wood KS, Byrns RE. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Nat Acad Sci USA 1987; 84: 9265-9269
4. Palmer RMJ, Ferrige AC, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
5. Myers PR, Minor RL, Guerra R, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 1990; 345: 161-163
6. Taylor SG, Weston AH. Endothelium-derived hyperpolarizing factor: A new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci 1988; 9: 272-274
7. Hecker M, Bara AT, Bauersachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrom P450-derived arachidonic acid metabolite in mammals. J Physiol 1994; 481: 407-414